PGNYHealthcareMid-Cap

Progyny, Inc. Insider Trading Activity

Every SEC Form 4 insider transaction reported for Progyny, Inc. (PGNY), sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Are PGNY insiders buying or selling?

Progyny, Inc. insiders reported 4 open-market buys ($8.2M) and 394 sells ($1.2B) across 398 Form 4 filings — a net selling position of $1.2B.

Source: SEC EDGAR Form 4

Key Statistics (as of Jul 16, 2026)

Total Form 4 filings
398
SEC EDGAR
Insider filers
18
Insider buys (4)
$8.2M
Insider sells (394)
$1.2B

Insider sentiment

Net selling

Net insider flow of $1.2B in net selling.

Recent PGNY insider transactions

DateInsiderRoleTypeSharesPriceValue
Jul 16, 2026Melissa B CummingsChief Operating OfficerSale2.2K$31.60$70.9K
Jun 5, 2026Mark S. LivingstonCHIEF FINANCIAL OFFICERSale2.5K$25.50$64.2K
Jun 5, 2026Allison SwartzEVP, GCSale1.8K$25.04$45.0K
Jun 3, 2026Mark S. LivingstonCHIEF FINANCIAL OFFICERSale279$26.20$7.3K
Jun 3, 2026Cheryl ScottDirectorSale7.4K$26.39$196.3K
Jun 3, 2026Geoffrey ClappChief Product OfficerSale1.5K$25.58$39.1K
Jun 1, 2026Allison SwartzEVP, GCSale2.4K$25.46$61.1K
May 29, 2026Kevin K GordonDirectorSale5.5K$24.99$137.4K
May 21, 2026Mark S. LivingstonCHIEF FINANCIAL OFFICERSale8.3K$25.50$211.0K
May 21, 2026Melissa B CummingsChief Operating OfficerSale9.6K$25.00$239.4K
Mar 6, 2026Allison SwartzEVP, GCSale599$17.54$10.5K
Mar 4, 2026Allison SwartzEVP, GCSale6.9K$17.36$119.0K
Dec 8, 2025Allison SwartzEVP, GCSale530$24.59$13.0K
Dec 4, 2025Mark S. LivingstonCHIEF FINANCIAL OFFICERSale213$25.50$5.4K
Dec 2, 2025Allison SwartzEVP, GCSale2.4K$26.87$64.4K
Nov 19, 2025Mark S. LivingstonCHIEF FINANCIAL OFFICERSale21.3K$25.50$543.2K
Nov 17, 2025Peter AnevskiCHIEF EXECUTIVE OFFICERPurchase79.5K$24.29$1.9M
Sep 5, 2025Allison SwartzEVP, GCSale599$23.53$14.1K
Sep 2, 2025Allison SwartzEVP, GCSale2.4K$22.96$55.1K
Aug 13, 2025Kevin K GordonDirectorSale2.5K$22.04$55.1K
Jun 12, 2025Cheryl ScottDirectorSale2.7K$22.07$59.0K
Dec 26, 2024David J SchlangerExecutive ChairmanPurchase150.0K$14.68$2.2M
Dec 26, 2024Peter AnevskiCHIEF EXECUTIVE OFFICERPurchase209.5K$14.48$3.0M
Jul 18, 2024Michael E SturmerPRESIDENTSale9.0K$30.00$270.9K
Jul 1, 2024Cheryl ScottDirectorSale1.5K$28.39$41.5K

Showing the 25 most recent of 398 Form 4 filings for Progyny, Inc..

Most active PGNY insiders

  • Norman Payson109 filings
  • David J Schlanger79 filings
  • Peter Anevski70 filings
  • David Bonderman57 filings
  • Jennifer Bealer18 filings

Ask anything about PGNY insider activity

Use Trabud's AI agent to query Progyny, Inc.'s Form 4 history in plain English — "Show me PGNY CEO purchases this year" or compare it against any other ticker.

Open the AI agent

PGNY insider trading FAQ

Are Progyny, Inc. insiders buying or selling?

Across 398 SEC Form 4 filings, Progyny, Inc. (PGNY) insiders reported 4 open-market purchases totaling $8.2M and 394 sales totaling $1.2B. That is a net selling position of $1.2B.

How many insiders trade PGNY stock?

18 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Progyny, Inc.. The most recent filing was accepted on Jul 16, 2026.

Where does Trabud get PGNY insider trading data?

All PGNY insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Looking for another company? Browse all tracked companies.

Related Content